Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report

Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures

(2010) Mattia Maroso et al.   NATURE MEDICINE

Neurological comorbidity and epilepsy: implications for treatment

(2009) G. Zaccara   ACTA NEUROLOGICA SCANDINAVICA

Seizures in Patients with Multiple Sclerosis

(2009) Brendan J. Kelley et al.   CNS DRUGS

Refractory Epilepsy: A Clinically Oriented Review

(2009) Pedro Beleza   EUROPEAN NEUROLOGY

Barrier to electrical storms

(2009) Richard M. Ransohoff   NATURE

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab

(2009) Werner Wenning et al.   NEW ENGLAND JOURNAL OF MEDICINE

The role of cytokines in the pathophysiology of epilepsy

(2008) Annamaria Vezzani et al.   BRAIN BEHAVIOR AND IMMUNITY

Seizures in multiple sclerosis

(2008) Marcus Koch et al.   EPILEPSIA

White matter angiopathy is common in pediatric patients with intractable focal epilepsies

(2008) Michelle Hildebrandt et al.   EPILEPSIA

Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis

(2008) Jiyun V. Kim et al.   NATURE

Brain inflammation initiates seizures

(2008) Jonathan K Kleen et al.   NATURE MEDICINE

A role for leukocyte-endothelial adhesion mechanisms in epilepsy

(2008) Paolo F Fabene et al.   NATURE MEDICINE

Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex

(2007) K. Boer et al.   EPILEPSY RESEARCH

Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy

(2007) Teresa Ravizza et al.   NEUROBIOLOGY OF DISEASE